In the Rotterdam Study, a statistically significant increase in breast cancer risk associated with higher CRP levels at baseline was reported [143], whereas other authors did not find any significant association between circulating CRP and breast cancer risk [144–146]. The gene discussed is CRP; the disease is breast carcinoma.